Dr MARIUS An, huisarts
ActiveSummary
Dr MARIUS An, huisarts has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €617k and a net result of €111k. Equity is growing by ~25.5% per year across the filed fiscal years. Its solvency ranks better than 31% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
79
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability79▼-2
Solvency71▼-9
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45k at 30 days acceptable
Liquidity ample (current ratio 2.52 against 4.01 in 2023; short-term debt: 8.4% and cash: 13.6% of total assets), but 54% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 09-10-2025, 70 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
70 d late
2023
135 d late
2022
81 d late
2021
57 d late
2020
118 d late
2019
103 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Source amounts without an identifiable currency are assumed to be EUR.
Equity
€617k▲ 21.9%
2023 · €506k
2018: €157k
2019: €207k
2020: €256k
2021: €342k
2022: €417k
2023: €506k
2018 → 2024
Total assets
€1.34M▲ 45.3%
2023 · €924k
2018: €733k
2019: €750k
2020: €755k
2021: €801k
2022: €860k
2023: €924k
2018 → 2024
Net result
€111k▲ 24.8%
2023 · €89k
2018: €23k
2019: €49k
2020: €50k
2021: €86k
2022: €76k
2023: €89k
2018 → 2024
Working capital
€171k▼ 17.0%
2023 · €206k
2018: €33k
2019: €79k
2020: €171k
2021: €273k
2022: €356k
2023: €206k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€256k-€342k▲ 33.4%€417k▲ 22.1%€506k▲ 21.3%€617k▲ 21.9%
Operating result€63k-€105k▲ 68.1%€136k▲ 28.7%€133k▼ 2.0%€157k▲ 17.8%
Net result€50k-€86k▲ 72.4%€76k▼ 11.6%€89k▲ 17.7%€111k▲ 24.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 18% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.34M
Fixed assets
€1.06M ▲ 62.9%
Current assets
€283k ▲ 3.4%
Equity and liabilities €1.34M
Equity
€617k ▲ 21.9%
Debt
€725k ▲ 73.6%
Debt's share of the balance-sheet total rises from 45.2% to 54.0%. Equity and debt are higher.
Key figures and ratios
EBITDA
€194k▲
2023 · €169k
Cash flow
€149k▲
2023 · €125k
Current ratio
2.52▼
2023 · 4.01
Debt to equity
1.17▲
2023 · 0.82
ROE
18.0%▲
2023 · 17.6%
ROA
8.3%▼
2023 · 9.6%
Interest coverage
19.76▼
2023 · 30.92
Debt ≤ 1 year
€113k▲
2023 · €68k
Debt > 1 year
€601k▲
2023 · €349k
Income taxes
€48k▲
2023 · €39k
Staff costs
€31k=
2023 · €31k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 45 lines
Balance sheet
Code20232024
Assets
Total assets20/58€924k€1.34M▲
Fixed assets21/28€650k€1.06M▲
Tangible fixed assets22/27€650k€1.06M▲
Land and buildings22€646k€1.05M▲
Plant, machinery and equipment23€1k€610▼
Furniture and vehicles24€2k€5k▲
Current assets29/58€274k€283k▲
Amounts receivable within one year40/41€7k-
Trade receivables40€7k-
Current investments50/53€151k€101k▼
Cash at bank and in hand54/58€115k€183k▲
Deferred charges and accrued income490/1€2k-
Equity and liabilities
Total equity and liabilities10/49€924k€1.34M▲
Equity10/15€506k€617k▲
Contributions10/11€12k€12k=
Reserves13€494k€605k▲
Distributable reserves133€494k€605k▲
Amounts payable17/49€418k€725k▲
Amounts payable after more than one year17€349k€601k▲
Financial debts170/4€349k€601k▲
Amounts payable within one year42/48€68k€113k▲
Current portion of amounts payable after more than one year42€24k€41k▲
Trade debts44€12k€11k▼
Suppliers440/4€12k€11k▼
Taxes, remuneration and social security45€33k€60k▲
Taxes450/3€23k€54k▲
Remuneration and social security454/9€9k€6k▼
Other amounts payable47/48€526€491▼
Accrued charges and deferred income492/3-€11k
Income statement
Code20232024
Remuneration, social security and pensions62€31k€31k=
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€36k€38k▲
Other operating charges640/8€2k€58k▲
Gross operating margin9900€202k€283k▲
Operating profit (loss)9901€133k€157k▲
Financial income75/76B€790€12k▲
Recurring financial income75€790€12k▲
Financial charges65/66B€5k€10k▲
Recurring financial charges65€5k€10k▲
Profit (loss) for the period before taxes9903€128k€159k▲
Income taxes67/77€39k€48k▲
Profit (loss) for the period9904€89k€111k▲
Profit (loss) for the period to be appropriated9905€89k€111k▲
Appropriation of the result
Profit (loss) to be appropriated9906€89k€111k▲
Transfer to equity691/2€89k€111k▲
To other reserves6921€89k€111k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
09-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 70 days late
2024
31-12
Financial
Highest result since 2018net €111k ▲24.8%
Operating result €157k, net result €111k, both a record.
13-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 135 days late
2023
31-12
Financial
Equity above €500kEq €506k ▲21.3%
6 profitable years in a row build equity to €506k.
20-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 81 days late
2022
26-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 57 days late
2021
26-11
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 118 days late
2020
11-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 103 days late
2019
31-12
Financial
Equity above €200kEq €207k ▲31.3%
2 profitable years in a row build equity to €207k.
03-12
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 125 days late
2018
15-10
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 76 days late
2017
09-10
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 70 days late
2016
05-10
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 66 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ronse · 1 establishment unit since 2011
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Zuidstraat 119600 RonseGround area
370 m²
Building footprint
165 m²
Volume, LiDAR
1,686 m³
Parcel 45423E0558/00F000, Flanders · tallest building 17.2 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Dr Marius An, huisarts
since 20112.229.424.145
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 45423E0558/00F000 | Flanders | 370 m² | 1 · 164 m² | 17.2 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. DOBBELAERE SABINE
BE 0862.262.001
Boechout · Eq €617,073
CLAESSENS ENDOCRINOLOGIE
BE 0648.777.966
Léglise · Eq €617,466
TTS
BE 0671.792.997
Lasne · Eq €617,518
DOKTER GILIO
BE 0892.499.374
Maasmechelen · Eq €617,549
Dr. Van Imschoot Bart, gastro-enterologie
BE 0845.605.121
Maarkedal · Eq €616,835
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,261 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded26-05-2011
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
68201Renting and operating of own or leased residential real estate, excluding social housing
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.